Build the portfolio view
Start with a product inventory covering intended use, variants, existing evidence and priority markets. Singapore, Malaysia, Thailand and Hong Kong have distinct national systems. Their official regulator resources are the starting point for determining which local pathways and establishment roles apply.
Sequence work around readiness
Our recommended planning approach compares commercial priorities, documentation gaps, local representation and operational dependencies. Shared evidence can support efficient preparation, but national requirements still need to be checked. Do not assume that one approval guarantees another authority’s acceptance or a specific timeline.
Keep the operating model in the roadmap
A registration strategy should also identify who can import, distribute, maintain documentation and handle post-market communication. Agree country-specific owners and review points. These are project-management recommendations; the actual obligations remain subject to current local rules and product classification.
Official sources
HSA — Medical devices ↗MDA — Establishment License Information ↗Thai FDA — Manufacture / Import for Commercial Purposes ↗Hong Kong Medical Device Division — Frequently Asked Questions ↗Sources accessed on 14 November 2026. Planning recommendations are identified in the text. Requirements may change; confirm the current position with the relevant authority.